Inactive Instrument

Jiya Acquisition Corp. Stock

Equities

JYAC

US47760M1027

Investment Holding Companies

Dynamic Chart
Jiya Acquisition Corp.(NasdaqCM:JYAC) dropped from NASDAQ Composite Index CI
Jiya Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Jiya Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Jiya Acquisition Corp. announced that it has received $1.5 million in funding CI
Jiya Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Jiya Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Jiya Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
Jiya Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Jiya Acquisition Corp. Appoints Lori Friedman as Class I Director CI
Jiya Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Jiya Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Certain Class B Common Stock of Jiya Acquisition Corp. are subject to a Lock-Up Agreement Ending on 18-MAY-2021. CI
Jiya Acquisition Corp. Announces Earnings Results for the Period from August 27, 2020 to December 31, 2020 CI
Jiya Acquisition Corp. Announces Appointment of Board of Directors CI
Jiya Acquisition Corp. announced that it has received $5 million in funding from Jiya Holding Company, LLC CI
More news
Managers TitleAgeSince
Director of Finance/CFO 47 20-07-31
Members of the board TitleAgeSince
Chairman 56 20-10-31
Director/Board Member 65 20-11-17
Director/Board Member 63 20-11-17
More insiders
Jiya Acquisition Corp. is a blank check company. The Company's business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus its search on identifying a prospective target business in the biopharmaceutical sector. The Company has not conducted any operations and has not generated any revenues.
More about the company